Focus on Biologics
Thomas Reinke

Genomic profiling in cancer may open the door to the use of unproven therapies

Biologics in Development
Michael D. Dalzell
Legislation & Regulation
John Carroll

Argument about safety reflects biosimilars and brands jockeying for market share

Medication Management
Thomas Reinke

Edwin Webb, PharmD

Comprehensive medication management may improve outcomes in medical homes

The Formulary Files
Krishna Rutvij Patel, PharmD
News & Commentary
Frank Diamond